Efficacy of Transcatheter Arterial Chemoembolization Followed by Sorafenib for Intermediate/Advanced Hepatocellular Carcinoma in Patients in Japan: A Retrospective Analysis

BACKGROUND: Sorafenib might prevent hepatocellular carcinoma (HCC) recurrence caused by the promotion of neoangiogenesis after transarterial chemoembolization (TACE). OBJECTIVES: To evaluate the efficacy and safety of TACE followed by sorafenib for treating advanced HCC. PATIENTS AND METHODS: We ret...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Drug Investig
Main Authors: Ohki, Takamasa, Sato, Koki, Yamagami, Mari, Ito, Daisaku, Yamada, Tomoharu, Kawanishi, Koki, Kojima, Kentaro, Seki, Michiharu, Toda, Nobuo, Tagawa, Kazumi
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2015
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4621710/
https://ncbi.nlm.nih.gov/pubmed/26446004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-015-0333-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados